Crossmark

Lack of pharmacokinetic drug–drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors

Crossref DOI link: https://doi.org/10.1007/s00280-016-3125-4

Published Online: 2016-08-09

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Ding

Braiteh, Fadi

Lee, James J.

Denlinger, Crystal S.

Shepard, Dale R.

Chaudhary, Archana

Lin, Yong

Gao, Ling

Asakiewicz, Christopher

Nasroulah, Federico

LoRusso, Patricia
Funding

Funding for this research was provided by:

Eli Lilly and Company
License Information

License valid from 2016-08-09